Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 240-248

  Divine M ^a   Lepage, E ^a   Briere J ^a   Pautier, P ^a   Dupriez, B ^a   Lederlin, P ^a   Mineur, P ^a   Tilly, H ^a   Blanc, M ^a   Audhuy, B ^a   Herbrecht, R ^a   Coiffier, B ^a   Reyes, F ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINDESINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 9044243029     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.240     Document Type: Article

References (26)

1. Magrath IT, Lee YJ, Anderson T, et al: Prognostic factor in Burkitt's lymphoma. Cancer 45:1507-1104, 1980
2. Murphy SB, Bowman WP, Abromowitch M, et al: Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 4:1732-1739, 1986
3. Harris NL, Jaffe E, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 5:1361-1392, 1994
4. Miliauskas JR, Berard CW, Young RC, et al: Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types): The relevance of making this histologic distinction. Cancer 50:2115-2121, 1983
5. Levine AM, Pavlova Z, Pockros AW, et al: Small noncleaved follicular center cell lymphoma: Burkitt and non-Burkitt variants in the United States. I. Clinical features. Cancer 52:1073-1079, 1983
6. Lopez TM, Hagemeister FB, McLaughlin P, et al: Small non-cleaved cell lymphoma in adults: Superior results for stages I-III disease. J Clin Oncol 8:615-622, 1990
7. Levine PH, Cho BR, Connelly RR, et al: The American Burkitt lymphoma registry: A progress report. Ann Intern Med 83:31-36, 1975
8. Arseneau JC, Canellos GP, Banks PM, et al: American Burkitt's lymphoma: A clinicopathologic study of 30 cases. Clinical factors relating to prolonged survival. Am J Med 58:314-321, 1975
9. Magrath IT, Janus C, Edwards BK, et al: An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63:1102-1104, 1984
10. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
11. Philip T, Pinkerton R, Biron P, et al: Effective multi-agent chemotherapy in children with advanced B-cell lymphoma: Who remains the high-risk patients? Br J Haematol 65:159-162, 1987
12. Patte C, Michon J, Boufet E, et al: High survival rate of childhood B-cell lymphoma and leukemia (ALL) as result of the LMB89 protocol of the SFOP. Presented at the Annual Meeting of the American Society of Clinical Oncology, San Diego, CA, May 1992
13. Bernstein JI, Coleman CN, Strickler JG, et al: Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847-858, 1986
14. Straus DJ, Wong GY, Liu J, et al: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: Results with treatment designed for acute lymphoblastic leukemia. Am J Med 90:328-331, 1991
15. McMasters ML, Greer JP, Greco FA, et al: Effective treatment of small non-cleaved cell lymphoma with high intensity, brief duration chemotherapy. J Clin Oncol 9:941-946, 1991
16. Bernasconi C, Brusamolino E, Pagnucco G, et al: Burkitt's lymphoma/leukemia: A clinicopathologic study on 24 adult patients. Leukemia 5:90-94, 1991
17. Zinzani PL, Gherlinzoni F, Bendandi M, et al: Adult Burkitt's lymphoma: Clinical and prognostic evaluation of 20 patients. Leuk and Lymph 14:465-470, 1994
18. Longo DL, Duffey PL, Jaffe ES, et al: Diffuse small non-cleaved-cell, non-Burkitt's lymphoma in adults: A high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 10:2153-2159, 1994
19. Coiffier B, Gisselbrecht C, Herbrecht R, et al: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with agressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
20. The International Non Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for agressive non-Hodgkin's Lymphoma. N Engl J Med 329:987-994, 1993
21. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860-1861, 1971
22. Ziegler JL, Magrath IT: Burkitt's Lymphoma. Pathobiol Ann 4:129-142, 1974
23. Soussain C, Patte C, Ostronoff M, et al: Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB (B-cell non Hodgkin's lymphoma and B-ALL) pediatric protocols. Blood 3:664-674, 1995
24. Grogan TM, Warnke RA, Kaplan HS: A comparative study of Burkitt's and non-Burkitt's "undifferentiated" malignant lymphoma: Immunologic, cytochemical, ultrastructural, cytologic, histolopathologic, clinical and cell culture features. Cancer 49:1817-1828, 1982
25. Hutchinson RE, Murphy SB, Fairclough DL, et al: Diffuse small noncleaved-cell lymphoma in children, Burkitt's versus non-Burkitt's types: Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital. Cancer 64:23-28, 1989
26. Yano T, van Krieken JHJM, Magrath IT, et al: Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79:1282-1290, 1992